Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial

BACKGROUND: Children hospitalised with severe anaemia in malaria endemic areas in Africa are at high risk of readmission or death within 6 months post-discharge. Currently, no strategy specifically addresses this period. In Malawi, 3 months of post-discharge malaria chemoprevention (PMC) with monthl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwambai, Titus K., Dhabangi, Aggrey, Idro, Richard, Opoka, Robert, Kariuki, Simon, Samuels, Aaron M., Desai, Meghna, van Hensbroek, Michael Boele, John, Chandy C., Robberstad, Bjarne, Wang, Duolao, Phiri, Kamija, ter Kuile, Feiko O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220494/
https://www.ncbi.nlm.nih.gov/pubmed/30400934
http://dx.doi.org/10.1186/s13063-018-2972-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220494/
https://www.ncbi.nlm.nih.gov/pubmed/30400934
http://dx.doi.org/10.1186/s13063-018-2972-1

Ejemplares similares